cp wire

CP Wire Articles

Adamas Announces Positive Results from Ph III Study of Gocovri in Parkinson’s Patients with Dyskinesia


Adamas Pharmaceuticals, Inc. (Nasdaq:ADMS) On 4/19/18 announced positive data from EASE LID 2, the company’s two-year Phase 3 open-label study of GOCOVRI™ (amantadine) extended release... read more

Thu, 04/19/18 - 09:14 am
Teva and Procter & Gamble Sever OTC Partnership


Teva has announced that Teva and the Procter & Gamble Company [NYSE: PG] have agreed to terminate the PGT Healthcare partnership that the two companies established in 2011 to market OTC (... read more

Thu, 04/19/18 - 08:44 am
FDA Approves IND for OBI Pharma's OBI-3424 for a Ph I/II Study in AKR1C3 Solid Tumors

OBI Pharma, Inc., a Taiwan biopharma company (TPEx: 4174), today announced that the U.S. Food and Drug Administration (FDA) has cleared an investigational new drug (IND) application for a Phase I/... read more

Thu, 04/19/18 - 08:35 am
Roche Receives FDA Approval for New Indication for cobas EGFR Mutation Test v2 as a Companion Diagnostic With Tagrisso
  • New indication as a companion diagnostic with AstraZeneca's Tagrisso (osimertinib) in first line treatment of patients with non-small cell lung cancer (NSCLC)
  • Results for EGFR... read more
Thu, 04/19/18 - 12:13 am
Rigel Proposes Stock Offering on Heels of Tavalisse Approval

Fresh on the announcement that the FDA had approved... read more

Wed, 04/18/18 - 05:31 pm

Pages